Arbeitsgemeinschaft Gynaekologische Onkologie Austria   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Innsbruck Austria

Organization Overview

First Clinical Trial
2005
NCT00189553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Arbeitsgemeinschaft Gynaekologische Onkologie Austria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 3)

Endometrial Neoplasms (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Hypersensitivity (Phase 3)

Neoplasms (Phase 3)

Ovarian Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7